Market closed
Passage Bio/$PASG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Passage Bio
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
Ticker
$PASG
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
60
Website
Passage Bio Metrics
BasicAdvanced
$21M
-
-$1.07
1.55
-
Price and volume
Market cap
$21M
Beta
1.55
52-week high
$0.55
52-week low
$0.30
Average daily volume
169K
Financial strength
Current ratio
4.07
Quick ratio
3.964
Long term debt to equity
35.566
Total debt to equity
41.586
Management effectiveness
Return on assets (TTM)
-32.20%
Return on equity (TTM)
-75.07%
Valuation
Price to book
0.33
Price to tangible book (TTM)
0.33
Price to free cash flow (TTM)
-0.415
Growth
Earnings per share change (TTM)
-42.49%
3-year earnings per share growth (CAGR)
-32.43%
Passage Bio News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Passage Bio stock?
Passage Bio (PASG) has a market cap of $21M as of April 20, 2025.
What is the P/E ratio for Passage Bio stock?
The price to earnings (P/E) ratio for Passage Bio (PASG) stock is 0 as of April 20, 2025.
Does Passage Bio stock pay dividends?
No, Passage Bio (PASG) stock does not pay dividends to its shareholders as of April 20, 2025.
When is the next Passage Bio dividend payment date?
Passage Bio (PASG) stock does not pay dividends to its shareholders.
What is the beta indicator for Passage Bio?
Passage Bio (PASG) has a beta rating of 1.55. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.